BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 20929702)

  • 1. Evaluation of congenital heart diseases and thyroid abnormalities in children with Down syndrome.
    Mıhçı E; Akçurin G; Eren E; Kardelen F; Akçurin S; Keser I; Ertuğ H
    Anadolu Kardiyol Derg; 2010 Oct; 10(5):440-5. PubMed ID: 20929702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism.
    Sack J; Shafrir Y; Urbach D; Amado O
    Pediatr Res; 1985 Oct; 19(10):1037-9. PubMed ID: 3932951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroxine-Based Screening for Congenital Hypothyroidism in Neonates with Down Syndrome.
    Erlichman I; Mimouni FB; Erlichman M; Schimmel MS
    J Pediatr; 2016 Jun; 173():165-8. PubMed ID: 26995701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trisomy 21 causes persistent congenital hypothyroidism presumably of thyroidal origin.
    van Trotsenburg AS; Kempers MJ; Endert E; Tijssen JG; de Vijlder JJ; Vulsma T
    Thyroid; 2006 Jul; 16(7):671-80. PubMed ID: 16889491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-thyroxine therapy and growth processes in children with Down syndrome.
    Kowalczyk K; Pukajło K; Malczewska A; Król-Chwastek A; Barg E
    Adv Clin Exp Med; 2013; 22(1):85-92. PubMed ID: 23468266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid function from birth to adolescence in Prader-Willi syndrome.
    Sharkia M; Michaud S; Berthier MT; Giguère Y; Stewart L; Deladoëy J; Deal C; Van Vliet G; Chanoine JP
    J Pediatr; 2013 Sep; 163(3):800-5. PubMed ID: 23623517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of thyroid dysfunctions in infants and children with Down Syndrome (DS) and the effect of thyroxine treatment on linear growth and weight gain in treated subjects versus DS subjects with normal thyroid function: a controlled study.
    AlAaraj N; Soliman AT; Itani M; Khalil A; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):36-42. PubMed ID: 31544805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Euthyroid submedian free T4 and subclinical hypothyroidism may have a detrimental clinical effect in Down syndrome.
    Tenenbaum A; Lebel E; Malkiel S; Kastiel Y; Abulibdeh A; Zangen DH
    Horm Res Paediatr; 2012; 78(2):113-8. PubMed ID: 22922417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma thyrotropin bioactivity in Down's syndrome children with subclinical hypothyroidism.
    Konings CH; van Trotsenburg AS; Ris-Stalpers C; Vulsma T; Wiedijk BM; de Vijlder JJ
    Eur J Endocrinol; 2001 Jan; 144(1):1-4. PubMed ID: 11174830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of congenital heart disease patients with subclinical hypothyroidism.
    Martínez-Quintana E; Rodríguez-González F
    Cardiol Young; 2015 Aug; 25(6):1111-8. PubMed ID: 25247450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of thyroid function in the first year of life in infants with Down syndrome.
    Feldman PM; Rodriguez N; Morrison E; Barton B; Lee MM
    Eur J Pediatr; 2023 Jun; 182(6):2903-2911. PubMed ID: 37059961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid dysfunction in patients with Down syndrome.
    Chen MH; Chen SJ; Su LY; Yang W
    Acta Paediatr Taiwan; 2007; 48(4):191-5. PubMed ID: 18265539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concentration of thyrotropic hormone and free thyroxin in children with Down's syndrome].
    Jiménez-López V; Arias A; Arata-Bellabarba G; Vivas E; Delgado MC; Paoli M
    Invest Clin; 2001 Jun; 42(2):123-30. PubMed ID: 11416978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down Syndrome and thyroid gland.
    Hasanhodzić M; Tahirović H; Lukinac L
    Bosn J Basic Med Sci; 2006 Aug; 6(3):38-42. PubMed ID: 16995846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk for non-autoimmune hypothyroidism in young patients with congenital heart defects.
    Passeri E; Frigerio M; De Filippis T; Valaperta R; Capelli P; Costa E; Fugazzola L; Marelli F; Porazzi P; Arcidiacono C; Carminati M; Ambrosi B; Persani L; Corbetta S
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1115-9. PubMed ID: 21525159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Congenital Heart Disease Affect Neurodevelopmental Outcomes in Children with Down Syndrome?
    Alsaied T; Marino BS; Esbensen AJ; Anixt JS; Epstein JN; Cnota JF
    Congenit Heart Dis; 2016; 11(1):26-33. PubMed ID: 26914309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid Stimulating Hormone Level at Diagnosis as a Predictor of Persistent Subclinical Hypothyroidism in Children with Down Syndrome.
    Sankar HV; Anjukrishna K; Riaz I
    Indian Pediatr; 2018 Jul; 55(7):576-578. PubMed ID: 30129539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid dysfunction in patients with Down syndrome: Results from a multi-institutional registry study.
    Lavigne J; Sharr C; Elsharkawi I; Ozonoff A; Baumer N; Brasington C; Cannon S; Crissman B; Davidson E; Florez JC; Kishnani P; Lombardo A; Lyerly J; McDonough ME; Schwartz A; Berrier K; Sparks S; Stock-Guild K; Toler TL; Vellody K; Voelz L; Skotko BG
    Am J Med Genet A; 2017 Jun; 173(6):1539-1545. PubMed ID: 28332275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of hypothyroidism in Down's syndrome.
    Cebeci AN; Güven A; Yıldız M
    J Clin Res Pediatr Endocrinol; 2013; 5(2):116-20. PubMed ID: 23748065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased neonatal thyrotropin in Down syndrome.
    Myrelid A; Jonsson B; Guthenberg C; von Döbeln U; Annerén G; Gustafsson J
    Acta Paediatr; 2009 Jun; 98(6):1010-3. PubMed ID: 19239410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.